Monoclonal antibodies specific for Hantaan virus

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Hantaan virus poses a significant public health threat, causing severe hemorrhagic fever with renal syndrome.
• Understanding the antigenic properties of Hantaan virus is crucial for developing diagnostic tools and vaccines.
• Monoclonal antibodies offer high specificity for characterizing viral antigens.

Purpose of the Study:

• To establish hybridoma cell lines producing monoclonal antibodies against Hantaan virus.
• To characterize the specificity and reactivity of these monoclonal antibodies.
• To investigate the antigenic relationships among different Hantaan virus strains and related viruses.

Main Methods:

• Hybridoma technology: Fusion of NS-1 mouse myeloma cells with spleen cells from Hantaan virus-immunized mice.
• Immunoblotting analysis and immunofluorescence assays to determine antibody specificity.
• Antigenic cross-reactivity testing with Hantaan virus strains, Prospect Hill virus, and the virus of nephropathia epidemica.

Main Results:

• Six hybridoma cell lines producing monoclonal antibodies to Hantaan virus were successfully established.
• Five antibodies recognized cell surface and cytoplasmic antigens; one recognized a cytoplasmic determinant.
• Two antibodies identified a 50,000 MW polypeptide in infected cells and purified virus.
• Three antibodies distinguished between Hantaan virus strains (Lee vs. 76-118); three recognized shared determinants.
• No cross-reactivity was observed with Prospect Hill virus or the virus of nephropathia epidemica.

Conclusions:

• The developed monoclonal antibodies are specific tools for Hantaan virus research.
• These antibodies can differentiate between Hantaan virus strains, aiding in epidemiological studies.
• The antibodies demonstrate the distinct antigenic nature of Hantaan virus compared to Prospect Hill virus and the virus of nephropathia epidemica.